Cyber Resilience

CVE-2023-22022

Medium

Published: 18 July 2023

Published
18 July 2023
Modified
21 November 2024
KEV Added
Patch
CVSS Score v3.1 6.5 CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
EPSS Score 0.0045 64.0th percentile
Risk Priority 13 60% EPSS · 20% KEV · 20% CVSS

Summary

CVE-2023-22022 is a medium-severity an unspecified weakness vulnerability in Oracle Health Sciences Applications. Its CVSS base score is 6.5 (Medium).

Operationally, ranked in the top 36.0% of CVEs by exploit likelihood; it is not currently listed in the CISA KEV catalog.

EU & UK References

Vulnerability details

Vulnerability in the Oracle Health Sciences Sciences Data Management Workbench product of Oracle Health Sciences Applications (component: Blinding Functionality). Supported versions that are affected are 3.1.0.2, 3.1.1.3 and 3.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via…

more

HTTP to compromise Oracle Health Sciences Sciences Data Management Workbench. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Health Sciences Sciences Data Management Workbench accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N).

CWE(s)

Related Threats

No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.

Affected Assets

oracle
health sciences applications
3.1.0.2, 3.1.1.3, 3.2.0.0

Mitigating Controls

No mitigating controls mapped yet. The per-CVE control annotator has not reached this CVE.

References